Objectives: Excessive oxidative stress and diminished antioxidant defences could contribute to age-related tissue damage and various diseases including age-related osteoporosis. Dendrobium officinale polysaccharides (DOPs), a major ingredient from a traditional Chinese medicine, have a great potential of antioxidative activity. In this study, we explore the role of DOP in age-related osteoporosis that remains elusive. 
age-related diseases, such as osteoporosis, osteoarthritis, diabetes, cardiovascular diseases and neurodegeneration. [3] [4] [5] [6] [7] [8] It has been reported that oxidative stress is recognized as an independent factor involved in age-related bone loss and could be associated with insufficient number of osteoblast and bone formation rate. 3,9,10 Domazetovic et al demonstrated that oxidative stress impaired bone formation and subsequently contributed age-related osteoporosis via attenuating osteoblastic differentiation. 11 During ageing, bone marrow stem cells (BMSCs) tend to differentiate into adipocytes rather than osteoblasts, which subsequently lead to progressive MAT accumulation and bone loss. 10, 12, 13 The imbalance between bone and fat in age-related osteoporosis has been reported to be associated with an increasingly proinflammatory tissue environment with mounting oxidative stress. [14] [15] [16] Conversely, peroxisome proliferator-activated receptor coactivator 1-a (PGC-1a), with property of antioxidative defence, had an anti-osteoporotic role though promoting osteogenesis and inhibiting adipogenesis.
14 Dendrobium officinale, a traditional Chinese health medicine, has received much attention in recent years due to its pharmacological properties. 17, 18 Dendrobium officinale polysaccharides (DOPs)
are a major ingredient in Dendrobium officinale, which was reported to possess a wide range of potential effects including antioxidative, anti-inflammatory, immunomodulation, anticancer, anti-obesity, antihypertensive, hypoglycaemic and neuron protection activity.
19-22
Previous studies have shown that Dendrobium officinale extract can prevent the osteoporosis in ovariectomized mice. 23 Moreover, ZHAO et al revealed that DOP has a great role in regulating cell fate of BMSCs. 24 It could inhibit adipogenic differentiation in Rat BMSCs by deregulating adipogenesis-related gene expression of PPARγ, LPL and FABP4. 24 However, the role of DOP in age-related bone loss and lineage commitment of BMSCs is still unclear.
Here, the present study demonstrates that DOP, as an antioxidative reagent, can attenuate oxidative stress damage and subsequently regulate age-related BMSCs lineage commitment shift whose effects are related to Nrf2-mediated antioxidative response.
Taken together, our study provides potential therapeutic effect of DOP in age-related osteoporosis.
| MATERIAL S AND ME THODS

| Mice
The 15-month-old mice were orally administrated with normal saline (NS) and DOP (150 mg/kg), respectively, once daily for 3 months.
All protocols of animal care and experiment were reviewed and ap- 
| Mouse BMSCs isolate and cell culture
Mouse BMSCs isolation was described as before. 13 Briefly, the cells were incubated with Sca-1, CD29, CD45 and CD11b (BioLegend)
after bone marrow cells were flushed from femora bone marrow cavity. Then, we sorted out Sca-1 + CD29+CD45−CD11b-BMMSCs through flow cytometry. Next, cultured the cell with low-glucose DMEM, 100 U/mL of penicillin/streptomycin and 10% FBS in a humidified atmosphere of 95% air and 5% CO 2 at 37 °C.
| Human bone marrow collection
We obtained the written informed consent from all participants before collecting bone marrow. The age of the participants was ranged from 20 to 79 years underwent hip replacement. All clinical bone marrows were approved by the Ethics Committee of the Xiangya
Hospital of Central South University, and this study conformed to recognized standards.
| Detection of cell viability
Cell viability was assessed by the methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay according to manufacturer's instructions.
The absorbance was measured at 570 nm using a Multiskan™ GO microplate reader (Thermo Fisher Scientific).
| Osteogenic differentiation and mineralization assay
BMSCs were cultured in 6-well plates at a density of 2. 
| Adipogenic differentiation
BMSCs were cultured with adipogenesis induction medium (DMEM containing 10% FBS, 0.5 mmol/L 3-isobutyl-1-methylxanthine, 5 μg/ mL insulin and 1 μmol/L dexamethasone) for 14 days. We performed oil red O staining to detect mature adipocytes and quantified oil red released from the cell into the isopropanol solution by spectrophotometry at 540 nm according to previous protocol. 
| Western blot and qRT-PCR analysis
We performed Western blotting as previously described. 26 The primary antibodies, NRF2 (ab62352; Abcam) or α-tubulin (11224-1-AP; Proteintech), were incubated overnight, then incubated with appropriate HRP-conjugated secondary antibodies for 1 hour at room temperature. The blots were visualized using ECL detection reagents. For qRT-PCR analysis, total RNA from cultured cells was extracted using Trizol reagent (Invitrogen) and then performed qPCR using PrimeScript RT reagent Kit (Takara) and SYBR Green PCR Master Mix (Takara). Primer sequences are listed in Tables S1 and S2.
| RNA interference experiments (siRNA)
Nrf2 siRNA was purchased from Riobio. Nrf2 siRNA was transfected into MCSs using Lipofectamine 2000 (Invitrogen) according to manufacturer's recommendations.
| H 2 O 2 treatment and antioxidant activity
Human MSCs were pre-exposed to 100 μmol/L H 2 O 2 for 2 hours.
The level of SOD and MDA in BMSCs was determined by MDA assay kit and SOD assay kit (Nangjing Jiancheng Bioengineering
Institution) following the instruction of manufacturer.
| Micro-CT analysis
The femurs were dissected from mice and fixed with 4% paraformaldehyde overnight, then scanned and analysed with high-resolution micro-CT (Skyscan 1172, Bruker MicroCT) as previously described. 13 We selected the region of interest for analysis as 5% of femoral 
| Immunohistochemistry analysis
Freshly, femora were dissected from mice, fixed overnight at 4℃
with 4% paraformaldehyde, decalcified in 10% EDTA (pH 7.4) for 
| Calcein double labelling
We injected mice intraperitoneally with 0.08% calcein (SigmaAldrich, 20 mg/kg bw) 8 and 2 days before euthanasia. Calcein double labelling in undecalcified bone slices was observed under a fluorescence microscope. Four randomly selected visual fields in the distal metaphysis of the femur were measured to test trabecular bone formation in femora.
| Statistics
Data are presented as mean ± SD. We used two-tailed Student's t test for 2-group comparison and one-way ANOVA for comparison within multiple groups. All experiments were conducted at least three times, and representative experiments were shown. P < 0.05 was considered as significant difference. Together, these results suggested that DOP stimulated osteoblastic differentiation and suppressed adipocytic differentiation of BMSCs.
| RE SULTS
| DOP stimulated osteoblast differentiation and inhibited adipocyte differentiation in BMSCs
| DOP regulated differentiation of BMSCs through activating Nrf2 signalling
DOP has been reported to be associated with antioxidative activity through NRF2 signalling pathway. 
| NRF2 expression level in human BMSCs was decreased during ageing
Ageing is always accompanied with increased oxidative stress. We isolated and cultured human BMSCs (hBMSCs) from male subjects at different ages. Compared to young group, the old group represented a remarkable decrease in SOD activity which indicated antioxidative capability ( Figure 4A ) and an increase in MDA level which indicated oxidative stress level ( Figure 4B ). These data implied an elevated level of oxidative stress in hBMSCs during ageing. Specifically, the expression of NRF2 was notably downregulated with ageing both at mRNA level and protein level ( Figure 4C,D) . Alternatively, qRT-PCR analysis revealed that antioxidative enzymes were correlated with NRF2 ( Figure 4C ). These results support that antioxidant NRF2 signalling plays an important role in the ageing process.
| DOP treatment attenuated bone loss and MAT accumulation in aged mice
To investigate the therapeutic effects of DOP in oxidative stress and age-related osteoporosis in vivo, we treated the 15-month-old mice with normal saline (NS) and DOP, respectively. DOP was orally admin- 
| D ISCUSS I ON
Age-related bone loss is becoming a growing public health problem as the progressive ageing population. [1] [2] [3] It urgently requires us to find some potential therapeutic targets and agents to prevent the development of bone loss. [29] [30] [31] In this study, we confirmed the potential therapeutic target of NRF2 in age-related bone loss and the protective role of DOP in attenuating the oxidative stress-impaired osteoblast differentiation. It is well established that oxidative stress is prerequisites for the progression in skeletal ageing and osteoporosis. including bone loss. 33 These results indicated that NRF2 antioxidant activity was dispensable for age-related diseases.
NRF2 is regarded as the master regulator of the cellular antioxidant response and a therapeutic target of oxidative-mediated diseases. [34] [35] [36] It is also a controversial player in bone metabolism.
28,37-39
Preliminary reports suggested overexpression of Nrf2 enhanced the potential of BMSCs to differentiate into osteogenic lineage and inhibited the potential to differentiate into adipogenic lineage.
34,38
Moreover, the deletion of Nrf2 in mice leads to a lower bone mass and an bone microarchitecture. 40, 41 In our study, we utilized hBMSCs from different age subjects to detect the relationships among age-related Data are represented as mean ± SD of three individual experiments Statistical significance was determined using Student's t test for A-C, E-F and M-R, and analysis of variance (ANOVA) for H-K. *P < 0.05. **P < 0.01 DOP is a major ingredient in Dendrobium officinale and known with its antioxidant activity. 44 Some work suggested the protective role of Dendrobium officinale in bone mass and natural ageing-induced premature ovarian failure. 45 In consistent with previous protective results, our study found that DOP remarkably increased osteogenesis and decreased adipogenesis in BMSCs, which could contribute to prevent age-related bone loss. Moreover, some studies showed that DOP had a positive effect on activating Nrf2 signalling. 27 In this paper, we demonstrated that BMSCs showed deficient osteogenesis and enhanced adipogenesis when exposure to oxidative stress, and the treatment of DOP could reverse this effect. However, this effect rescued by DOP treatment was absent in Nrf2-knockdown BMSCs. Moreover, we also validated its anti-osteoporosis activity assessed by remarkably restored bone loss and MAT accumulation in the treated mice, which were accompanied with upregulated defence against oxidative stress.
Together, these findings imply that DOP controls age-related lineage commitment of BMSCs and bone-fat balance by activating antioxidant NRF2 signalling ( Figure 6 ). Our study demonstrates a rationale therapeutic target and a potential anabolic agent in age-related bone loss.
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